SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R. Branche, Nadine G. Rouphael, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, Jennifer A. Whitaker, Susan J. Little, View ORCID ProfileEvan J. Anderson, Emmanuel B. Walter, Richard M. Novak, Richard Rupp, Lisa A. Jackson, Tara M. Babu, Angelica C. Kottkamp, Anne F. Luetkemeyer, Lilly C. Immergluck, Rachel M. Presti, Martín Bäcker, Patricia L. Winokur, Siham M. Mahgoub, Paul A. Goepfert, Dahlene N. Fusco, Elissa Malkin, Jeffrey M. Bethony, Edward E. Walsh, Daniel S. Graciaa, Hady Samaha, Amy C. Sherman, Stephen R. Walsh, Getahun Abate, Zacharoula Oikonomopoulou, Hana M. El Sahly, Thomas C.S. Martin, Christina A. Rostad, Michael J. Smith, Benjamin G. Ladner, Laura Porterfield, Maya Dunstan, Anna Wald, Tamia Davis, Robert L. Atmar, Mark J. Mulligan, Kirsten E. Lyke, Christine M. Posavad, Megan A. Meagher, David S. Stephens, Kathleen M. Neuzil, Kuleni Abebe, Heather Hill, Jim Albert, Teri C. Lewis, Lisa A. Giebeig, Amanda Eaton, Antonia Netzl, Samuel H. Wilks, Sina Türeli, Mamodikoe Makhene, Sonja Crandon, Marina Lee, Seema U. Nayak, David C. Montefiori, Mat Makowski, Derek J. Smith, Paul C. Roberts, John H. Beigel, the COVAIL Study Group
doi: https://doi.org/10.1101/2022.07.12.22277336
Angela R. Branche
1Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY
MDNadine G. Rouphael
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MDDavid J. Diemert
3George Washington University, Washington, DC
MDAnn R. Falsey
1Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY
MDCecilia Losada
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MDLindsey R. Baden
4Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
MDSharon E. Frey
5Saint Louis University, School of Medicine, Saint Louis, MO
MDJennifer A. Whitaker
6Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX
MDSusan J. Little
7Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA
MDEvan J. Anderson
8Center for Childhood Infections and Vaccines (CCIV) of Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA
MDEmmanuel B. Walter
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
MD, MPHRichard M. Novak
10University of Illinois at Chicago-Project WISH, Chicago, IL
MDRichard Rupp
11University of Texas Medical Branch, Galveston, TX
MDLisa A. Jackson
12Kaiser Permanente Washington Health Research Institute, Seattle, WA
MD, MPHTara M. Babu
13Department of Medicine, University of Washington, Seattle, Washington, WA
MD, MSCIAngelica C. Kottkamp
14New York University VTEU, Manhattan Research Clinic at NYU Grossman School of Medicine, New York, NY
MDAnne F. Luetkemeyer
15Zuckerberg San Francisco General, University of California San Francisco, San Francisco, CA
MDLilly C. Immergluck
16Morehouse School of Medicine, Atlanta, GA
MD, MSRachel M. Presti
17Washington University School of Medicine, Saint Louis, MO
MD, PhDMartín Bäcker
18New York University VTEU, Long Island Research Clinic at NYU Long Island School of Medicine, New York, NY
MDPatricia L. Winokur
19University of Iowa College of Medicine, Iowa City, IA
MDSiham M. Mahgoub
20Howard University College of Medicine, Howard University Hospital, Washington, DC
MDPaul A. Goepfert
21University of Alabama at Birmingham, Birmingham, AL
MDDahlene N. Fusco
22Tulane University School of Medicine, New Orleans, LA
MDElissa Malkin
3George Washington University, Washington, DC
DOJeffrey M. Bethony
3George Washington University, Washington, DC
PhDEdward E. Walsh
1Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY
MDDaniel S. Graciaa
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MDHady Samaha
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MDAmy C. Sherman
4Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
MDStephen R. Walsh
4Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
MDGetahun Abate
5Saint Louis University, School of Medicine, Saint Louis, MO
MD, PhDZacharoula Oikonomopoulou
5Saint Louis University, School of Medicine, Saint Louis, MO
MDHana M. El Sahly
6Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX
MDThomas C.S. Martin
7Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA
MDChristina A. Rostad
8Center for Childhood Infections and Vaccines (CCIV) of Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA
MDMichael J. Smith
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
MD, MSCEBenjamin G. Ladner
10University of Illinois at Chicago-Project WISH, Chicago, IL
MDLaura Porterfield
11University of Texas Medical Branch, Galveston, TX
MDMaya Dunstan
12Kaiser Permanente Washington Health Research Institute, Seattle, WA
MS, RNAnna Wald
23Departments of Medicine, Epidemiology, and Laboratory Medicine & Pathology, University of Washington, Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA
MD, MPHTamia Davis
14New York University VTEU, Manhattan Research Clinic at NYU Grossman School of Medicine, New York, NY
NPRobert L. Atmar
6Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX
MDMark J. Mulligan
14New York University VTEU, Manhattan Research Clinic at NYU Grossman School of Medicine, New York, NY
MDKirsten E. Lyke
24Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
MDChristine M. Posavad
23Departments of Medicine, Epidemiology, and Laboratory Medicine & Pathology, University of Washington, Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA
25IDCRC Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, WA
PhDMegan A. Meagher
25IDCRC Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, WA
BSDavid S. Stephens
26Emory University, Atlanta, GA
MDKathleen M. Neuzil
24Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
MDKuleni Abebe
27FHI360, Durham, NC
MScHeather Hill
28The Emmes Company, LLC, Rockville, MD
MSJim Albert
28The Emmes Company, LLC, Rockville, MD
MSTeri C. Lewis
29Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD
BSLisa A. Giebeig
29Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD
MSAmanda Eaton
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
30The Department of Surgery, Duke University Medical Center, Durham, NC
MBAAntonia Netzl
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
MScSamuel H. Wilks
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
PhD, MDSina Türeli
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
PhDMamodikoe Makhene
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
MDSonja Crandon
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
BSNMarina Lee
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
PhDSeema U. Nayak
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
MDDavid C. Montefiori
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
30The Department of Surgery, Duke University Medical Center, Durham, NC
PhDMat Makowski
28The Emmes Company, LLC, Rockville, MD
PhDDerek J. Smith
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
PhDPaul C. Roberts
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
PhDJohn H. Beigel
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
MD
Article usage
Posted July 15, 2022.
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R. Branche, Nadine G. Rouphael, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, Jennifer A. Whitaker, Susan J. Little, Evan J. Anderson, Emmanuel B. Walter, Richard M. Novak, Richard Rupp, Lisa A. Jackson, Tara M. Babu, Angelica C. Kottkamp, Anne F. Luetkemeyer, Lilly C. Immergluck, Rachel M. Presti, Martín Bäcker, Patricia L. Winokur, Siham M. Mahgoub, Paul A. Goepfert, Dahlene N. Fusco, Elissa Malkin, Jeffrey M. Bethony, Edward E. Walsh, Daniel S. Graciaa, Hady Samaha, Amy C. Sherman, Stephen R. Walsh, Getahun Abate, Zacharoula Oikonomopoulou, Hana M. El Sahly, Thomas C.S. Martin, Christina A. Rostad, Michael J. Smith, Benjamin G. Ladner, Laura Porterfield, Maya Dunstan, Anna Wald, Tamia Davis, Robert L. Atmar, Mark J. Mulligan, Kirsten E. Lyke, Christine M. Posavad, Megan A. Meagher, David S. Stephens, Kathleen M. Neuzil, Kuleni Abebe, Heather Hill, Jim Albert, Teri C. Lewis, Lisa A. Giebeig, Amanda Eaton, Antonia Netzl, Samuel H. Wilks, Sina Türeli, Mamodikoe Makhene, Sonja Crandon, Marina Lee, Seema U. Nayak, David C. Montefiori, Mat Makowski, Derek J. Smith, Paul C. Roberts, John H. Beigel, the COVAIL Study Group
medRxiv 2022.07.12.22277336; doi: https://doi.org/10.1101/2022.07.12.22277336
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R. Branche, Nadine G. Rouphael, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, Jennifer A. Whitaker, Susan J. Little, Evan J. Anderson, Emmanuel B. Walter, Richard M. Novak, Richard Rupp, Lisa A. Jackson, Tara M. Babu, Angelica C. Kottkamp, Anne F. Luetkemeyer, Lilly C. Immergluck, Rachel M. Presti, Martín Bäcker, Patricia L. Winokur, Siham M. Mahgoub, Paul A. Goepfert, Dahlene N. Fusco, Elissa Malkin, Jeffrey M. Bethony, Edward E. Walsh, Daniel S. Graciaa, Hady Samaha, Amy C. Sherman, Stephen R. Walsh, Getahun Abate, Zacharoula Oikonomopoulou, Hana M. El Sahly, Thomas C.S. Martin, Christina A. Rostad, Michael J. Smith, Benjamin G. Ladner, Laura Porterfield, Maya Dunstan, Anna Wald, Tamia Davis, Robert L. Atmar, Mark J. Mulligan, Kirsten E. Lyke, Christine M. Posavad, Megan A. Meagher, David S. Stephens, Kathleen M. Neuzil, Kuleni Abebe, Heather Hill, Jim Albert, Teri C. Lewis, Lisa A. Giebeig, Amanda Eaton, Antonia Netzl, Samuel H. Wilks, Sina Türeli, Mamodikoe Makhene, Sonja Crandon, Marina Lee, Seema U. Nayak, David C. Montefiori, Mat Makowski, Derek J. Smith, Paul C. Roberts, John H. Beigel, the COVAIL Study Group
medRxiv 2022.07.12.22277336; doi: https://doi.org/10.1101/2022.07.12.22277336
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)